GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Realcan Pharmaceutical Group Co Ltd (SZSE:002589) » Definitions » Accounts Receivable

Realcan Pharmaceutical Group Co (SZSE:002589) Accounts Receivable : ¥3,908 Mil (As of Sep. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Realcan Pharmaceutical Group Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Realcan Pharmaceutical Group Co's accounts receivables for the quarter that ended in Sep. 2023 was ¥3,908 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Realcan Pharmaceutical Group Co's Days Sales Outstanding for the quarter that ended in Sep. 2023 was 176.10.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Realcan Pharmaceutical Group Co's Net-Net Working Capital per share for the quarter that ended in Sep. 2023 was ¥-2.01.


Realcan Pharmaceutical Group Co Accounts Receivable Historical Data

The historical data trend for Realcan Pharmaceutical Group Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Realcan Pharmaceutical Group Co Accounts Receivable Chart

Realcan Pharmaceutical Group Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17,162.62 15,638.58 13,723.61 10,285.10 4,112.37

Realcan Pharmaceutical Group Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,921.44 4,112.37 4,110.91 3,968.48 3,908.13

Realcan Pharmaceutical Group Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Realcan Pharmaceutical Group Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Realcan Pharmaceutical Group Co's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=3908.131/2025.13*91
=176.10

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Realcan Pharmaceutical Group Co's accounts receivable are only considered to be worth 75% of book value:

Realcan Pharmaceutical Group Co's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2023 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(5597.495+0.75 * 3908.131+0.5 * 788.333-11731.513
-0-212.601)/1504.71
=-2.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Realcan Pharmaceutical Group Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Realcan Pharmaceutical Group Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Realcan Pharmaceutical Group Co (SZSE:002589) Business Description

Traded in Other Exchanges
N/A
Address
No. 326, Airport Road, Zhifu District, Shandong Province, Yantai, CHN, 264004
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.

Realcan Pharmaceutical Group Co (SZSE:002589) Headlines

No Headlines